Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.59 |
| ▸ | NPC1 | O15118 | 6/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | CCR6 | P51684 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL400890 | 0.84 | RAB9A (0.77) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL11298577 | 0.83 | RAB9A (0.75) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL6967578 | 0.83 | RAB9A (0.63) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL12324391 | 0.82 | RAB9A (0.82) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL9825195 | 0.81 | RAB9A (0.61) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL6967575 | 0.81 | RAB9A (0.61) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL11797334 | 0.81 | ALDH1A1 (0.64) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL10309466 | 0.80 | SMN1; SMN2 (0.74) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA | |
| SCHEMBL2988075 | 0.80 | ALDH1A1 (0.73) | SMN1; SMN2ALDH1A1GAAPOLBKDM4E | |
| SCHEMBL37273 | 0.79 | ALDH1A1 (0.68) | RAB9ANPC1SMN1; SMN2ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737462-B2 | Methods for modulating plant response to environmentally-induced stress | HOWARD UNIVERSITY (US) | 2023-08-29 | — | — | US | disclosed |
| US-20150119250-A1 | METHODS FOR MODULATING PLANT RESPONSE TO ENVIRONMENTALLY-INDUCED STRESS | GEORGETOWN UNIVERSITY | 2015-04-30 | — | — | US | disclosed |
| US-3936481-A | Hydrazono-1,3,2-dithiarsetanes, -stannetanes and -stibitanes | AMERICAN CYANAMID COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11737462-B2 | Methods for modulating plant response to environmentally-induced stress | RACK1, ROS1, HSF1 | RAB9A 176/4885NPC1 4575/4885SMN1; SMN2 4793/4885 |
| US-20150119250-A1 | METHODS FOR MODULATING PLANT RESPONSE TO ENVIRONMENTALLY-INDUCED STRESS | RACK1, ROS1, HSF1 | RAB9A 176/4885NPC1 4575/4885SMN1; SMN2 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.